Building trust with a Native community
Tribal council’s historic visit strengthens relationship with UW’s health researchers...
17 September, 2024
Diversity
Diversity Action Plans for Clinical Trials: Evaluating FDA’s Draft Guidance
The FDA is intent on improving the enrollment of participants -- also known as "subjects" -- from underrepresented populations in clinical studies for drugs and devices....
06 September, 2024
HIV is On the Rise Among Black Americans. Clinical Trials Can Change That
The CDC reported that African/Black American and Hispanic/Latino individuals are disproportionately impacted by HIV, accounting for over 70% of the estimated new HIV infections in 2022....
28 August, 2024
Optimized Design Offers Fast Track to Inclusive Clinical Trials
Diversity in clinical research has become a hot topic in recent years, with heightened attention leading to dramatic changes in the regulatory framework, including U.S. legislation broadening the scope of diversity consideration in clinical trials....
14 August, 2024
Why Black women are pushing to diversify health care industry
As a Black psychologist of Barbadian descent, Jackman knew she was looking for a therapist of color who had experience working with couples. The search, however, proved to be more challenging than she expected....
12 August, 2024
How Clinical Research Can Be A Path To Clinical Care For Minority Health
More inclusive clinical research can and will improve health outcomes for women, especially those from minority backgrounds who are disproportionately affected by breast cancer....
12 July, 2024
Actionable Diversity Plans for Clinical Trial Recruitment and Retention
Diversity action plans—focused on enrolling representative numbers of participants in clinical trials from historically underrepresented racial and ethnic populations—are part of U.S. Food and Drug Administration (FDA) draft guidance published in April 2022....
01 July, 2024
FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies
Today, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist medical product sponsors in submitting Diversity Action Plans to support certain clinical studies....
26 June, 2024
Improving Cardiovascular Research for Transgender and Gender Diverse Populations
Transgender and gender diverse (TGGD) individuals face an increased risk of cardiovascular disease (CVD). There is an unmet need to identify the root causes of CVD health disparities in this population....
13 June, 2024
Why We Need Black Men for Prostate Cancer Clinical Trials
The American Cancer Society reported that in 2024, they estimate there will be approximately 299,010 new cases of prostate cancer and around 35,250 new deaths attributed to the disease....
05 June, 2024